EP1083841A1 — Disease management/training system and method
Assigned to Glaxo Group Ltd · Expires 2001-03-21 · 25y expired
What this patent protects
This invention is a computer (110) implemented disease management, and training method. The method can be used to training asthma patients self-management skills. The method includes creating, storing, processing the relevant data (101) to a patient's condition, and producing out…
USPTO Abstract
This invention is a computer (110) implemented disease management, and training method. The method can be used to training asthma patients self-management skills. The method includes creating, storing, processing the relevant data (101) to a patient's condition, and producing output reports (141) to health care personnel.
Drugs covered by this patent
- Cutivate (FLUTICASONE PROPIONATE) · Teva Pharm
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.